X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
nuclear medicine (21) 21
female (19) 19
humans (19) 19
middle aged (17) 17
breast cancer (16) 16
life sciences (13) 13
adult (12) 12
index medicus (12) 12
male (12) 12
[ sdv.ib.mn ] life sciences [q-bio]/bioengineering/nuclear medicine (11) 11
aged (11) 11
bioengineering (11) 11
oncology (10) 10
prognosis (9) 9
tomography (9) 9
cancer (7) 7
chemotherapy (7) 7
fluorodeoxyglucose f18 (7) 7
medicine & public health (7) 7
radiopharmaceuticals (7) 7
adolescent (6) 6
cardiology (6) 6
follow-up studies (6) 6
imaging / radiology (6) 6
medical prognosis (6) 6
orthopedics (6) 6
positron-emission tomography (6) 6
treatment outcome (6) 6
neoplasm staging (5) 5
pet imaging (5) 5
radionuclide imaging (5) 5
therapy (5) 5
tumors (5) 5
aged, 80 and over (4) 4
analysis (4) 4
angiogenesis (4) 4
biopsy (4) 4
breast neoplasms - diagnostic imaging (4) 4
glucose metabolism (4) 4
iodine radioisotopes - therapeutic use (4) 4
multimodal imaging (4) 4
predictive value of tests (4) 4
prospective studies (4) 4
radiology, nuclear medicine & medical imaging (4) 4
tomography, x-ray computed (4) 4
tumor (4) 4
adjuvant treatment (3) 3
animals (3) 3
breast neoplasms - drug therapy (3) 3
brustkrebs (3) 3
cancer therapies (3) 3
carcinoma (3) 3
carcinoma, hepatocellular - radiotherapy (3) 3
chemotherapie (3) 3
diastolic function (3) 3
disease-free survival (3) 3
glucose (3) 3
kidney - metabolism (3) 3
kidney - pathology (3) 3
liver neoplasms - radiotherapy (3) 3
medical imaging (3) 3
metabolism (3) 3
pet (3) 3
positron-emission-tomography (3) 3
positronen-emissions-computertomographie (3) 3
rats (3) 3
reproducibility of results (3) 3
sensitivity and specificity (3) 3
survival (3) 3
survival analysis (3) 3
thyroid neoplasms - radiotherapy (3) 3
vorhersage (3) 3
young adult (3) 3
[sdv.can]life sciences [q-bio]/cancer (2) 2
anthracycline cardiotoxicity (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
blood flow (2) 2
bone marrow (2) 2
breast neoplasms - metabolism (2) 2
carcinoma - diagnostic imaging (2) 2
carcinoma, hepatocellular - diagnostic imaging (2) 2
carcinoma, papillary - radiotherapy (2) 2
child (2) 2
clinical trials (2) 2
comparative analysis (2) 2
cyclophosphamide (2) 2
development and progression (2) 2
diagnosis (2) 2
disease (2) 2
disease progression (2) 2
fdg-pet (2) 2
heart-failure (2) 2
hepatic artery (2) 2
immunohistochemistry (2) 2
injections, intra-arterial (2) 2
iodine radioisotopes - pharmacokinetics (2) 2
iodized oil - administration & dosage (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1984, ISBN 2070700581, 109
Short story where pen and thoughts run wild through the reflexions and souvenirs of the author's life. 
Book
by Vilgrain, Valérie and Pereira, Helena and Assenat, Eric and Guiu, Boris and Ilonca, Alina Diana and Ilonca, Alina D and Pageaux, Georges-Philippe and Sibert, Annie and Bouattour, Mohamed and Lebtahi, Rachida and Allaham, Wassim and Barraud, Hélène and Laurent, Valérie and Mathias, Elodie and Bronowicki, Jean-Pierre and Tasu, Jean-Pierre and Perdrisot, Rémy and Silvain, Christine and Gerolami, René and Mundler, Olivier and Seitz, Jean-Francois and Vidal, Vincent and Aubé, Christophe and Oberti, Frédéric and Couturier, Olivier and Brenot-Rossi, Isabelle and Raoul, Jean-Luc and Sarran, Anthony and Costentin, Charlotte and Itti, Emmanuel and Luciani, Alain and Adam, René and Lewin, Maïté and Samuel, Didier and Ronot, Maxime and Dinut, Aurelia and Castera, Laurent and Chatellier, Gilles and Delhom - Christol, Elisabeth and Lonjon, Julie and Abdel-Rehim, Mohamed and Dieudonné, Arnaud and Bazin, Christophe and Chagneau-Derrode, Carine and Borentain, Patrick and Bouvier, Antoine and Vervueren, Laurent and Chalaye, Julia and Kobeiter, Hicham and Edeline, Julien and Garin, Etienne and Rolland, Yan and Archambeaud, Isabelle and Eugene, Thomas and Frampas, Eric and Cassinotto, Christophe and Guyot, Martine and Hiriart, Jean-Baptiste and Lapuyade, Bruno and Vergniol, Julien and Bachellier, Philippe and Detour, Julien and Duclos, Bernard and Greget, Michel and Habersetzer, Francois and Imperiale, Alessio and Merle, Philippe and Rode, Agnès and Morvan, Julie and Nguyen-Khac, Eric and Yzet, Thierry and Baudin, Guillaume and Chevallier, Patrick and Mahamat, Abakar and Piche, Thierry and Razzouk, Micheline and Hillon, Patrick and Loffroy, Romaric and Toubeau, Michel and Vincent, Julie and Barabino, Gabriele and Bouarioua, Nadia and Cuilleron, Muriel and Ecochard, Marie and Prevot-Bitot, Nathalie and Leroy, Vincent and Roux, Julie and Sengel, Christian and Bourcier, Valérie and Ganne-Carrie, Nathalie and Seror, Olivier and Costo, Sylvie and Dao, Thông and Pelage, Jean-Pierre and Dumortier, Jérôme and Giammarile, Francesco and Valette, Pierre-Jean and Ghazzar, Nadia and Pellerin, Olivier and Taieb, Julien and ... and SARAH Trial Grp and SARAH Trial Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1624 - 1636
Sorafenib is the recommended treatment for patients with advanced hepatocellular carcinoma. We aimed to compare the efficacy and safety of sorafenib to that of... 
SURVIVAL | THERAPY | ONCOLOGY | COMPETING RISK | TRANSARTERIAL CHEMOEMBOLIZATION | RADIOEMBOLIZATION | QUALITY-OF-LIFE | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Follow-Up Studies | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Liver Neoplasms - mortality | Dose-Response Relationship, Drug | Microspheres | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Neoplasm Invasiveness - pathology | Phenylurea Compounds - adverse effects | Adult | Female | Liver Neoplasms - pathology | Yttrium Radioisotopes - therapeutic use | Radiotherapy Dosage | Drug Administration Schedule | Administration, Oral | Brachytherapy - methods | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Niacinamide - adverse effects | Carcinoma, Hepatocellular - radiotherapy | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Liver Neoplasms - radiotherapy | Sorafenib | Carcinoma, Hepatocellular - pathology | Survival Analysis | Aged | Neoplasm Staging | Rare earth metals | Antimitotic agents | Product development | Hepatoma | Comparative analysis | Radiotherapy | Antineoplastic agents | Life Sciences | Liver Neoplasms/drug therapy | Phenylurea Compounds/administration & dosage | Yttrium Radioisotopes/therapeutic use | Niacinamide/analogs & derivatives | Carcinoma, Hepatocellular/radiotherapy | Carcinoma, Hepatocellular/drug therapy | Cancer
Journal Article
1998, Chʻopʻan., ISBN 9788984010062, 111
Book
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 12/2011, Volume 130, Issue 3, pp. 845 - 854
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 3/2014, Volume 41, Issue 3, pp. 416 - 427
The objective of this study was to evaluate, in the luminal human epidermal growth factor receptor 2 (HER2)-negative breast cancer subtype, the prognostic... 
Neoadjuvant chemotherapy | Medicine & Public Health | Luminal | Orthopedics | Oncology | Breast cancer | Nuclear Medicine | Imaging / Radiology | Cardiology | Monitoring | 18 F-FDG PET | F-FDG PET
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 3/2014, Volume 41, Issue 3, pp. 428 - 437
The objective of this study was to assess the impact on management and the prognostic value of 18F-fluorodeoxyglucose (FDG) positron emission tomography... 
Prognosis | Medicine & Public Health | Orthopedics | Oncology | Breast cancer | Nuclear Medicine | Primary staging | Imaging / Radiology | Cardiology | FDG PET/CT
Journal Article
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 11/2016, Volume 57, Issue 11, p. 1707
  Previous studies have suggested that early changes in blood flow (BF) in response to neoadjuvant chemotherapy and evaluated with ^sup 15^O-water are a... 
Nuclear medicine | Chemotherapy | Tomography | Biomarkers | Breast cancer | Blood pressure
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 11/2016, Volume 57, Issue 11, pp. 1707 - 1707
Previous studies have suggested that early changes in blood flow (BF) in response to neoadjuvant chemotherapy and evaluated with super( 15)O-water are a... 
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 08/2013, Volume 54, Issue 8, p. 1244
  In newly diagnosed diffuse large B-cell lymphoma (DLBCL), the sensitivity of bone marrow biopsy (BMB) for the detection of bone marrow involvement (BMI) can... 
Nuclear medicine | Body mass index | Survival analysis | Biopsy | Bone marrow | Tomography | Lymphomas
Journal Article